TMCnet News
Nephros Announces Presentations at Five Upcoming Investor ConferencesSOUTH ORANGE, NJ, Sept. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced presentations at five upcoming investor conferences. Daron Evans, President and Chief Executive Officer, and Andy Astor, Chief Operating and Financial Officer, will provide overviews of Nephros’ business during the conferences and will be available for one-on-one meetings with registered participants. Company information, including the most recent corporate presentation, is available on the Nephros website: https://www.nephros.com/investor-relations/ LD Micro San Francisco Summit RHK Capital 2019 Disruptive Growth Conference For more information and webcast: http://disruptnyc.com Fall Investor Summit MicroCap Leadership Summit For more information: https://microcapclub.com/summit/ LD Micro New York City Summit About Nephros, Inc. Nephros is a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets. Nephros ultrafilters are used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from water, providing barriers that assist in improving infection control in showers, sinks, and ice machines. Additionally, Nephros ultrafilters are used by dialysis centers for assisting in the added removal of endotoxins and other biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and patients. Nephros filters, including AETHER™ brand filters, improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Nephros and AETHER™ products are used in the health care, food service, hospitality, and convenience store markets. For more information about Nephros, please visit our website at www.nephros.com. Investor Relations Contact: Kirin Smith, President PCG Advisory, Inc. (646) 863-6519 [email protected] |